Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor that is being investigated for ulcerative colitis (UC). Tofacitinib is approved for rheumatoid arthritis and psoriatic arthritis, where it has been shown to increase herpes zoster (HZ) risk. We evaluated HZ risk among UC patie...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Inflamm Bowel Dis
Glavni autori: Winthrop, Kevin L, Melmed, Gil Y, Vermeire, Séverine, Long, Millie D, Chan, Gary, Pedersen, Ronald D, Lawendy, Nervin, Thorpe, Andrew J, Nduaka, Chudy I, Su, Chinyu
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Original Clinical Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6140434/
https://ncbi.nlm.nih.gov/pubmed/29850873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy131
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items